Instil Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
Instil Bio, Inc. (TIL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 2.52 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-07.
Discontinued › Notes
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2022-03-07
- Instil Bio, Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2021 was 2.52M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 12 month |
|---|---|
| 2021-12-31 | 2.52M shares 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |